عربي For Healthcare professionals

The Happiness Survey

To be always happy, the happy pill will help you ask the right
questions for your doctor, check the below:

HOW DIFFICULT IS IT FOR YOU
TO DELAY EJACULATION?
DO YOU EJACULATE BEFORE
YOU WANT TO?

According to
medical studies

  • Dapoxetine is the first and only drug in the world specially formulated and safe to treat premature ejaculation in men.
  • An increase in penetration time reached 4 times .
  • 60% of users described the results of the ability to control ejaculation as good or very good
  • 60% of users described the results of sexual satisfaction as good or very good
  • 77% of users rated the results generally good or very good

Primary Premature
ejaculation

Primary Premature ejaculation
In which the man has premature ejaculation since the beginning of his sexual life and does not improve over time, most cases of premature ejaculation are due to organic reasons related to the substance Serotonin or nerve receptors of their own.

Acquired Premature
ejaculation

Acquired Premature ejaculation
In which the man is normal at the beginning of his sexual life and after a short or long period, he suffers premature ejaculation. This type is highly affected by psychological and social conditions, but may also result from certain diseases such as prostatitis or inflammation in the back of the urethra or some medications.

This is a questionnaire to help identify men who may have a problem with ejaculating too soon during sexual activity. Even if you do not have difficulties, please answer all the questions.

  • Please circle the number that best represents your answer for each of the questions below
  • Please circle only one number for each question
  • Remember there are no right or wrong answers to these questions
  • While your experiences may change from time to time, what we need to know is your general experience with intercourse.
PLEASE NOTE:
Ejaculation refers to the release of semen after penetration (i.e. when your penis enters your partner)
TEST NOW
  • How difficult is it for you to delay ejaculation?
  • Not difficult at all Somewhat difficult Moderately difficult Very difficult Extremely difficult
    Not difficult at all
    Somewhat difficult
    Moderately difficult
    Very difficult
    Extremely difficult
  • Do you ejaculate before you want to?
  • Never or almost never (0%) Less than half the time (25%) About half the time (50%) Over half the time (75%) Always or almost always (100%)
    Never or almost never (0%)
    Less than half the time (25%)
    About half the time (50%)
    Over half the time (75%)
    Always or almost always (100%)
  • Do you ejaculate with very little stimulation?
  • Never or almost never (0%) Less than half the time (25%) About half the time (50%) Over half the time (75%) Always or almost always (100%)
    Never or almost never (0%)
    Less than half the time (25%)
    About half the time (50%)
    Over half the time (75%)
    Always or almost always (100%)
  • Do you feel frustrated because of ejaculating before you want to?
  • Not at all Slightly Moderately Very Extremely
    Not at all
    Slightly
    Moderately
    Very
    Extremely
  • How concerned are you that your time to ejaculation leaves your partner unfulfilled?
  • Not at all Slightly Moderately Very Extremely
    Not at all
    Slightly
    Moderately
    Very
    Extremely

Important Safety Information


PREVALENCE
OF PE

Premature ejaculation (PE) is one of the most prevalent male sexual complaints


ssris

Of patients on chronic SSRIs , 30–50% experience sexual side-effects
Chronic treatment with these SSRIs:
• Reduces libido
• Compromises erectile function,

Ref: KARL-ERIK ANDERSSON, JOHN P. MULHALL* and MICHAEL G. WYLLIE†Department of Clinical and Experimental Pharmacology, Lund University, Hospital, Lund, Sweden, Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA, † Urodoc Ltd, Herne, UK Accepted for publication 26 August 2005

The main differences between PE and ED

The main differences between PE and ED:

Premature ejaculation (PE)
  • No problem getting an erection suitable for sexual intercourse
  • Penis remains erect until ejaculation
  • Ejaculation occurs before the man wishes it, with low feelings of control over ejaculation, causing distress
  • Common in men of all ages
Erectile dysfunction (ED)
  • Difficulty in getting an erection suitable for sexual intercourse or in keeping the penis erect until the end of intercourse
  • Penis softens before ejaculation or before the end of sexual intercourse
  • Man may try to ejaculate quickly before he loses his erection
  • More common in older men

Ref. Food and Drug Administration, 2005.

DOSAGE &
ADMINISTRATION

The recommended starting dose for all patients is 30 mg to 60mg, taken as needed approximately 1 to 3 hours prior to sexual activity.
The maximum recommended dosing frequency is once every 24 hours.


TOLERABILITY/
SAFETY

By contrast, sexual side effects are infrequent with Dapoxetine.
On demand Dapoxetine has no significant adverse effects on:
o libido (<1%) or
o Erection (<4%)

Ref. KARL-ERIK ANDERSSON, JOHN P. MULHALL* and MICHAEL G. WYLLIE† Department of Clinical and Experimental Pharmacology, Lund University, Hospital, Lund, Sweden, *Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA, †Urodoc Ltd, Herne, UK Accepted for publication 26 August 2005

how to report side effects?

We believe our first responsibility is to the patients, doctors, pharmacists and other health care professionals. In meeting their needs, everything we do must be of high quality. By reporting side effects, you provide National Pharmacovigilance and Drug Safety Center(NPC) & Marketing Authorisation Holder with important feedback about our products.

To report any side effect: The National Pharmacovigilance and Drug Safety Center

  • Fax: +966-11-2057662
  • Email: Npc.drug@sfda.gov.sa
  • Online: http://ade.sfda.gov.sa
  • Toll free phone: 8002490000

Pharmacovigilance Department in Riyadh Pharma

  • Fax: +966-11-4065260
  • Email: khaleda@riyadhpharma.com
  • Tel: +966-11-4026150 ext. 242
  • Mobile: +966 501792530

Ref: KARL-ERIK ANDERSSON, JOHN P. MULHALL* and MICHAEL G. WYLLIE†Department of Clinical and Experimental Pharmacology, Lund University, Hospital, Lund, Sweden,Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA, † Urodoc Ltd, Herne, UK Accepted for publication 26 August 2005

Medication Guide